INSUBCONTINENT EXCLUSIVE:
Pharma buys parts of Sandoz US from Novartis for $900 million)"US states filed a second lawsuit in Federal Court similarly alleging that
Aurobindo and other companies in the US generic drug industry had violated antitrust laws by fixing prices and allocating customers (the
'Second State AG Action')," Aurobindo Pharma said in a regulatory filing.The company said the "Second State AG Action" includes additional
parties and additional products which were not referenced in the "First State AG Action" .In December 2016, the Attorney General (AG) of the
State of Connecticut along with the Attorneys' General of various other US states filed a lawsuit in Federal Court alleging that Aurobindo
and other companies in the US generic drug industry had violated antitrust laws by fixing prices and allocating customers - the "First State
AG Action"."On 18 June 2018, an amended complaint was filed in the First State AG Action
Aurobindo has denied all the relevant accusations in the First State AG Action and is vigorously defending against the matter," the company
said.The statement said the company is reviewing the "Second State AG Action and expect that we will be filing papers with the Federal Court
in due course denying each of the relevant accusations".Aurobindo does not, at this juncture, anticipate that these matters will have a
and election schedule for Lok Sabha Elections 2019 on TheIndianSubcontinent.com/elections
Like us on Facebook or follow us on Twitter and Instagram for updates from each of the 543 parliamentary seats for the 2019 Indian general
Election results will be out on May 23.
